FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that the Company has approved a seven-day extension of the Company’s pending subscription rights offering to 5:00 p.m., New York City time, on June 22, 2009, unless further extended by the Company. Pursuant to the subscription rights offering, each holder of record of the Company’s common stock as of April 21, 2009 received one non-transferable subscription right for each share of common stock owned by such holder on such date, except with respect to shares of common stock held by the BioMimetic 401K Plan. Each subscription right represents the right to purchase 0.1017 shares of the Company’s common stock at a price of $8.50 per share. The rights offering originally was scheduled to expire on June 15, 2009.
